If asked, some will equivocate and say they get their facts from medical journals and from published studies, but never from those pesky misleading ads.
Healthcare marketing has a head start in grooming women leaders. But it's by no means a fait accompli.
Perhaps we should always bear in mind the need to periodically reinvigorate and reshape our careers.
Apologies to Paul Simon, but there must be 50 ways to leave your employer.
In our struggle with the bean counters and the stockbrokers, can't we make patient needs a priority, too?
Finally, a Congress and president who see pharma as a resource and not a villain, Flaum writes.
In short, CEOs can't be afraid to walk away from their most profitable line if another approach may lead to improved long-term outcomes.
I'm not suggesting that colleges become vocational schools. But don't you think they should also help young people prepare for the life they're going to be living?
Now here comes the big question. Will the shareholders and directors of KaloBios and Allergan reward or punish their CEOs for what some may see as revenue-capping concessions?
You can see it everywhere: on TV and in newspapers and ads. The decades of struggle against cancer are paying off.